Crossmark

Combating Clinically Isolated Pathogens with Surfactin from a Newly Isolated Bacillus subtilis ZCK-1: from Strain Characterization to Therapeutic Potential

Crossref DOI link: https://doi.org/10.1134/S0003683825601428

Published Online: 2025-10-01

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, M. https://orcid.org/0009-0006-9381-1778
Dong, J.

Zhang, L.

Lv, Y.

Guo, Y.

Wang, Z.
License Information

Text and Data Mining valid from 2025-10-01

Version of Record valid from 2025-10-01
More Information

Article History

Received: 18 April 2025

Revised: 30 May 2025

Accepted: 5 July 2025

First Online: 1 October 2025

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

: The animal study protocol was approved by the Animal Ethics Review Committee of Baotou Medical College, Inner Mongolia University of Science and Technology (protocol code 056 and 2021.4.19).

: The authors of this work declare that they have no conflicts of interest.

Document is current

Any future updates will be listed below